Keiko Shibuya

Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame

Yasushi Nagata, Kenji Takayama, Yukinori Matsuo et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 675 citations

Medicine, Oncology, Radiation Oncology +17

Dose–Volume Metrics Associated With Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Lung Cancer

Yukinori Matsuo, Keiko Shibuya, Mitsuhiro Nakamura et al. · International Journal of Radiation Oncology*Biology*Physics · 2012 · 194 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival after Stereotactic Body Radiation Therapy for Lung Cancer

N. Ueki, Yukinori Matsuo, Yosuke Togashi et al. · Journal of Thoracic Oncology · 2014 · 177 citations · Full text

Medicine, Oncology, Radiation Oncology +16

The Akt/mTOR Pathway Assures the Synthesis of HIF-1α Protein in a Glucose- and Reoxygenation-dependent Manner in Irradiated Tumors

Hiroshi Harada, Satoshi Itasaka, Shinae Kizaka‐Kondoh et al. · Journal of Biological Chemistry · 2008 · 161 citations · Full text

Medicine, Molecular Biology, Oncology +17

Prognostic Factors in Stereotactic Body Radiotherapy for Non–Small-Cell Lung Cancer

Yukinori Matsuo, Keiko Shibuya, Yasushi Nagata et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 118 citations

Medicine, Oncology, Radiation Oncology +15